15
Participants
Start Date
September 30, 2012
Primary Completion Date
December 31, 2012
Study Completion Date
December 31, 2012
faldaprevir
medium dose of faldaprevir
faldaprevir
medium dose of faldaprevir
omeprazole
medium dose of omeprazole
faldaprevir
medium dose of faldaprevir
1220.59.1 Boehringer Ingelheim Investigational Site, Biberach
Lead Sponsor
Boehringer Ingelheim
INDUSTRY